Arbutus to Receive $116 Million Strategic Investment from Roivant Sciences

NEXT STORY
Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month
PREV STORY
Branch duct intraductal papillar mucinous neoplasms confer increased malignancy risk
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Appoints Sanjay Sehgal, Ph.D., to Chief Regulatory Affairs and Quality Assurance Officer

author_avatar
NASDAQ Market News

Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine

author_avatar
NASDAQ Market News

Trillium Granted 180-Day Extension by NASDAQ to Regain Compliance With Minimum Bid Price Rule

author_avatar
NASDAQ Market News